Search research articles
Contact Us
Filters
Showing results (31-40 of 58) with videos related to
Page
of 6
Sort By:
Medrxiv : the Preprint Server for Health Sciences
|
September 10, 2024
Estimating optimal therapeutic drug levels of anti-tuberculosis medications based on treatment safety and effectiveness
Gustavo Amorim, David W Haas, Marcelo Cordeiro-Santos, et al.
BMC Pulmonary Medicine
|
October 10, 2024
Implementation of spirometry screening for post-tuberculosis lung disease (PTLD) among adolescents and adults enrolled within the National Tuberculosis Control Program of Carmelo Hospital in Chókwè District, Mozambique: A hybrid type III effectiveness-implementation study protocol
Harriett Myers, Bartolomeu Chongo, Jerry S Zifodya, et al.
American Journal of Epidemiology
|
January 22, 2026
Analysis approaches to combine error-prone data with a subset of validated data: an application to a multinational study of Kaposi sarcoma and HIV
Joshua Slone, Gustavo Amorim, Aggrey Semeere, et al.
Acta Oncologica (Stockholm, Sweden)
|
January 5, 2018
A new approach for modeling patient overall radiosensitivity and predicting multiple toxicity endpoints for breast cancer patients
Chamberlain Mbah, Kim De Ruyck, Silke De Schrijver, et al.
BMC Public Health
|
November 26, 2025
A hybrid type III effectiveness-implementation study designed to test implementation best practices of deploying a Screen-Triage-Treat approach to cervical cancer screening and management utilizing self-collected HPV DNA testing in Chokwe District, Mozambique
Troy D Moon, Mila P Salcedo, Elzier Mavume-Mangunyane, et al.
American Journal of Epidemiology
|
November 25, 2025
Data validation in multinational observational studies with error-prone data: applying an optimal validation sampling strategy in a study of Kaposi sarcoma and HIV
Gustavo Amorim, Joshua Slone, Aggrey Semeere, et al.
BMC Medicine
|
August 13, 2021
Pregnancies among women living with HIV using contraceptives and antiretroviral therapy in western Kenya: a retrospective, cohort study
Rena C Patel, Gustavo Amorim, Beatrice Jakait, et al.
Lancet Regional Health. Americas
|
September 2, 2025
Corrigendum to "Effects of missed anti-tuberculosis therapy doses on treatment outcome: a multi-center cohort study"-The Lancet Regional Health-Americas 2025; Volume 48; 101162; August 2025
Isabella B B Ferreira, Rodrigo C Menezes, Mariana Araújo-Pereira, et al.
Lancet Regional Health. Americas
|
July 14, 2025
Effects of missed anti-tuberculosis therapy doses on treatment outcome: a multi-center cohort study
Isabella B B Ferreira, Rodrigo C Menezes, Mariana Araújo-Pereira, et al.
Journal of the International AIDS Society
|
September 8, 2022
Contraceptive implant use duration is not associated with breakthrough pregnancy among women living with HIV and using efavirenz: a retrospective, longitudinal analysis
Randy M Stalter, Gustavo Amorim, A Rain Mocello, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 58) with videos related to
Sort By:
Page
of 6
Medrxiv : the Preprint Server for Health Sciences
|
September 10, 2024
Estimating optimal therapeutic drug levels of anti-tuberculosis medications based on treatment safety and effectiveness
Gustavo Amorim, David W Haas, Marcelo Cordeiro-Santos, et al.
BMC Pulmonary Medicine
|
October 10, 2024
Implementation of spirometry screening for post-tuberculosis lung disease (PTLD) among adolescents and adults enrolled within the National Tuberculosis Control Program of Carmelo Hospital in Chókwè District, Mozambique: A hybrid type III effectiveness-implementation study protocol
Harriett Myers, Bartolomeu Chongo, Jerry S Zifodya, et al.
American Journal of Epidemiology
|
January 22, 2026
Analysis approaches to combine error-prone data with a subset of validated data: an application to a multinational study of Kaposi sarcoma and HIV
Joshua Slone, Gustavo Amorim, Aggrey Semeere, et al.
Acta Oncologica (Stockholm, Sweden)
|
January 5, 2018
A new approach for modeling patient overall radiosensitivity and predicting multiple toxicity endpoints for breast cancer patients
Chamberlain Mbah, Kim De Ruyck, Silke De Schrijver, et al.
BMC Public Health
|
November 26, 2025
A hybrid type III effectiveness-implementation study designed to test implementation best practices of deploying a Screen-Triage-Treat approach to cervical cancer screening and management utilizing self-collected HPV DNA testing in Chokwe District, Mozambique
Troy D Moon, Mila P Salcedo, Elzier Mavume-Mangunyane, et al.
American Journal of Epidemiology
|
November 25, 2025
Data validation in multinational observational studies with error-prone data: applying an optimal validation sampling strategy in a study of Kaposi sarcoma and HIV
Gustavo Amorim, Joshua Slone, Aggrey Semeere, et al.
BMC Medicine
|
August 13, 2021
Pregnancies among women living with HIV using contraceptives and antiretroviral therapy in western Kenya: a retrospective, cohort study
Rena C Patel, Gustavo Amorim, Beatrice Jakait, et al.
Lancet Regional Health. Americas
|
September 2, 2025
Corrigendum to "Effects of missed anti-tuberculosis therapy doses on treatment outcome: a multi-center cohort study"-The Lancet Regional Health-Americas 2025; Volume 48; 101162; August 2025
Isabella B B Ferreira, Rodrigo C Menezes, Mariana Araújo-Pereira, et al.
Lancet Regional Health. Americas
|
July 14, 2025
Effects of missed anti-tuberculosis therapy doses on treatment outcome: a multi-center cohort study
Isabella B B Ferreira, Rodrigo C Menezes, Mariana Araújo-Pereira, et al.
Journal of the International AIDS Society
|
September 8, 2022
Contraceptive implant use duration is not associated with breakthrough pregnancy among women living with HIV and using efavirenz: a retrospective, longitudinal analysis
Randy M Stalter, Gustavo Amorim, A Rain Mocello, et al.
Page
of 6